Optimize the use of current cytotoxic agents alone and in combination and promote the development of new targeted therapies for the treatment of ovarian cancer, endometrial cancer, and cervical cancer.
Current Studies
Appropriate dosing of chemotherapy agents in obesity
Compare and contrast efficacy of Doxil to generic liposomal doxorubicin
Modulation of acquired and inherent drug resistance
Long-term Goals
Improving treatment outcomes with better overall response rates and reducing treatment-related side effects for women with cancer